<!DOCTYPE html>
<html lang="en" dir="auto">

<head>
<head>
    <title>psychiatry and clinical psychology</title>
    <meta charset="utf-8">
    <meta name="description"
        content="Website meta description for google search results go here" />
    <meta name="dc.relation" content="https://trxiv.yorks0n.com" />
    <meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
    <meta name="theme-color" content="#1A94D2" />

    

    
    
    
    <link rel="stylesheet" href="/css/main.min.css" media="screen">

</head>


<meta charset="utf-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
<meta name="robots" content="index, follow">
<title>psychiatry and clinical psychology | TRxiv2</title>
<meta name="keywords" content="">
<meta name="description" content="Distinguishing different psychiatric disorders using DDx-PRS
Authors: Peyrot, W. J.; Panagiotaropoulou, G.; Olde Loohuis, L. M.; Adams, M.; Awasthi, S.; Ge, T.; McIntosh, A. M.; Mitchell, B. L.; Mullins, N.; O&#39;Connell, K. S.; Penninx, B. W. J. H.; Posthuma, D.; Ripke, S.; Ruderfer, D. M.; Uffelmann, E.; Vilhjalmsson, B. J.; Zhu, Z.; Schizophrenia Working Group of the Psychiatric Genomics Consortium, ; Bipolar Disorder Working Group of the Psychiatric Genomics Consortium, ; Major Depressive Disorder Working Group of the Psychiatric Genomics Consortium, ; Smoller, J.">
<meta name="author" content="">
<link rel="canonical" href="https://trxiv.yorks0n.com/posts/psychiatry-and-clinical-psychology/">
<link crossorigin="anonymous" href="/assets/css/stylesheet.904bd1e751cdd2a584fa6bed3fa1166dfd8ec9949ebfd0c4d69c5add5e17c23d.css" integrity="sha256-kEvR51HN0qWE&#43;mvtP6EWbf2OyZSev9DE1pxa3V4Xwj0=" rel="preload stylesheet" as="style">
<script defer crossorigin="anonymous" src="/assets/js/highlight.f413e19d0714851f6474e7ee9632408e58ac146fbdbe62747134bea2fa3415e0.js" integrity="sha256-9BPhnQcUhR9kdOfuljJAjlisFG&#43;9vmJ0cTS&#43;ovo0FeA="
    onload="hljs.initHighlightingOnLoad();"></script>
<link rel="icon" href="https://trxiv.yorks0n.com/favicon.ico">
<link rel="icon" type="image/png" sizes="16x16" href="https://trxiv.yorks0n.com/favicon-16x16.png">
<link rel="icon" type="image/png" sizes="32x32" href="https://trxiv.yorks0n.com/favicon-32x32.png">
<link rel="apple-touch-icon" href="https://trxiv.yorks0n.com/apple-touch-icon.png">
<link rel="mask-icon" href="https://trxiv.yorks0n.com/safari-pinned-tab.svg">
<meta name="theme-color" content="#2e2e33">
<meta name="msapplication-TileColor" content="#2e2e33">
<noscript>
    <style>
        #theme-toggle,
        .top-link {
            display: none;
        }

    </style>
    <style>
        @media (prefers-color-scheme: dark) {
            :root {
                --theme: rgb(29, 30, 32);
                --entry: rgb(46, 46, 51);
                --primary: rgb(218, 218, 219);
                --secondary: rgb(155, 156, 157);
                --tertiary: rgb(65, 66, 68);
                --content: rgb(196, 196, 197);
                --hljs-bg: rgb(46, 46, 51);
                --code-bg: rgb(55, 56, 62);
                --border: rgb(51, 51, 51);
            }

            .list {
                background: var(--theme);
            }

            .list:not(.dark)::-webkit-scrollbar-track {
                background: 0 0;
            }

            .list:not(.dark)::-webkit-scrollbar-thumb {
                border-color: var(--theme);
            }
        }

    </style>
</noscript><meta property="og:title" content="psychiatry and clinical psychology" />
<meta property="og:description" content="Distinguishing different psychiatric disorders using DDx-PRS
Authors: Peyrot, W. J.; Panagiotaropoulou, G.; Olde Loohuis, L. M.; Adams, M.; Awasthi, S.; Ge, T.; McIntosh, A. M.; Mitchell, B. L.; Mullins, N.; O&#39;Connell, K. S.; Penninx, B. W. J. H.; Posthuma, D.; Ripke, S.; Ruderfer, D. M.; Uffelmann, E.; Vilhjalmsson, B. J.; Zhu, Z.; Schizophrenia Working Group of the Psychiatric Genomics Consortium, ; Bipolar Disorder Working Group of the Psychiatric Genomics Consortium, ; Major Depressive Disorder Working Group of the Psychiatric Genomics Consortium, ; Smoller, J." />
<meta property="og:type" content="article" />
<meta property="og:url" content="https://trxiv.yorks0n.com/posts/psychiatry-and-clinical-psychology/" /><meta property="article:section" content="posts" />
<meta property="article:published_time" content="2024-02-14T10:38:48+00:00" />
<meta property="article:modified_time" content="2024-02-14T10:38:48+00:00" />

<meta name="twitter:card" content="summary"/>
<meta name="twitter:title" content="psychiatry and clinical psychology"/>
<meta name="twitter:description" content="Distinguishing different psychiatric disorders using DDx-PRS
Authors: Peyrot, W. J.; Panagiotaropoulou, G.; Olde Loohuis, L. M.; Adams, M.; Awasthi, S.; Ge, T.; McIntosh, A. M.; Mitchell, B. L.; Mullins, N.; O&#39;Connell, K. S.; Penninx, B. W. J. H.; Posthuma, D.; Ripke, S.; Ruderfer, D. M.; Uffelmann, E.; Vilhjalmsson, B. J.; Zhu, Z.; Schizophrenia Working Group of the Psychiatric Genomics Consortium, ; Bipolar Disorder Working Group of the Psychiatric Genomics Consortium, ; Major Depressive Disorder Working Group of the Psychiatric Genomics Consortium, ; Smoller, J."/>


<script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "BreadcrumbList",
  "itemListElement": [, 
    {
      "@type": "ListItem",
      "position":  2 ,
      "name": "Posts",
      "item": "https://trxiv.yorks0n.com/posts/"
    }, 
    {
      "@type": "ListItem",
      "position":  3 ,
      "name": "psychiatry and clinical psychology",
      "item": "https://trxiv.yorks0n.com/posts/psychiatry-and-clinical-psychology/"
    }
  ]
}
</script>
<script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "BlogPosting",
  "headline": "psychiatry and clinical psychology",
  "name": "psychiatry and clinical psychology",
  "description": "Distinguishing different psychiatric disorders using DDx-PRS\nAuthors: Peyrot, W. J.; Panagiotaropoulou, G.; Olde Loohuis, L. M.; Adams, M.; Awasthi, S.; Ge, T.; McIntosh, A. M.; Mitchell, B. L.; Mullins, N.; O\u0026#39;Connell, K. S.; Penninx, B. W. J. H.; Posthuma, D.; Ripke, S.; Ruderfer, D. M.; Uffelmann, E.; Vilhjalmsson, B. J.; Zhu, Z.; Schizophrenia Working Group of the Psychiatric Genomics Consortium, ; Bipolar Disorder Working Group of the Psychiatric Genomics Consortium, ; Major Depressive Disorder Working Group of the Psychiatric Genomics Consortium, ; Smoller, J.",
  "keywords": [
    
  ],
  "articleBody": " Distinguishing different psychiatric disorders using DDx-PRS\nAuthors: Peyrot, W. J.; Panagiotaropoulou, G.; Olde Loohuis, L. M.; Adams, M.; Awasthi, S.; Ge, T.; McIntosh, A. M.; Mitchell, B. L.; Mullins, N.; O'Connell, K. S.; Penninx, B. W. J. H.; Posthuma, D.; Ripke, S.; Ruderfer, D. M.; Uffelmann, E.; Vilhjalmsson, B. J.; Zhu, Z.; Schizophrenia Working Group of the Psychiatric Genomics Consortium, ; Bipolar Disorder Working Group of the Psychiatric Genomics Consortium, ; Major Depressive Disorder Working Group of the Psychiatric Genomics Consortium, ; Smoller, J. W.; Price, A. L.\nScore: 21.5, Published: 2024-02-04 DOI: 10.1101/2024.02.02.24302228\nDespite great progress on methods for case-control polygenic prediction (e.g. schizophrenia vs. control), there remains an unmet need for a method that genetically distinguishes clinically related disorders (e.g. schizophrenia (SCZ) vs. bipolar disorder (BIP) vs. depression (MDD) vs. control); such a method could have important clinical value, especially at disorder onset when differential diagnosis can be challenging. Here, we introduce a method, Differential Diagnosis-Polygenic Risk Score (DDx-PRS), that jointly estimates posterior probabilities of each possible diagnostic category (e.g. SCZ=50%, BIP=25%, MDD=15%, control=10%) by modeling variance/covariance structure across disorders, leveraging case-control polygenic risk scores (PRS) for each disorder (computed using existing methods) and prior clinical probabilities for each diagnostic category. DDx-PRS uses only summary-level training data and does not use tuning data, facilitating implementation in clinical settings. In simulations, DDx-PRS was well-calibrated (whereas a simpler approach that analyzes each disorder marginally was poorly calibrated), and effective in distinguishing each diagnostic category vs. the rest. We then applied DDx-PRS to Psychiatric Genomics Consortium SCZ/BIP/MDD/control data, including summary-level training data from 3 case-control GWAS (N=41,917-173,140 cases; total N=1,048,683) and held-out test data from different cohorts with equal numbers of each diagnostic category (total N=11,460). DDx-PRS was well-calibrated and well-powered relative to these training sample sizes, attaining AUCs of 0.66 for SCZ vs. rest, 0.64 for BIP vs. rest, 0.59 for MDD vs. rest, and 0.68 for control vs. rest. DDx-PRS produced comparable results to methods that leverage tuning data, confirming that DDx-PRS is an effective method. True diagnosis probabilities in top deciles of predicted diagnosis probabilities were considerably larger than prior baseline probabilities, particularly in projections to larger training sample sizes, implying considerable potential for clinical utility under certain circumstances. In conclusion, DDx-PRS is an effective method for distinguishing clinically related disorders.\nSub-second and multi-second dopamine dynamics underlie variability in human time perception\nAuthors: Sadibolova, R.; DiMarco, E. K.; Jiang, A.; Maas, B.; Tatter, S. B.; Laxton, A.; Kishida, K. T.; Terhune, D. B.\nScore: 7.5, Published: 2024-02-09 DOI: 10.1101/2024.02.09.24302276\nTiming behaviour and the perception of time are fundamental to cognitive and emotional processes in humans. In non-human model organisms, the neuromodulator dopamine has been associated with variations in timing behaviour, but the connection between variations in dopamine levels and the human experience of time has not been directly assessed. Here, we report how dopamine levels in human striatum, measured with sub-second temporal resolution during awake deep brain stimulation surgery, relate to participants perceptual judgements of time intervals. Fast, phasic, dopaminergic signals were associated with underestimation of temporal intervals, whereas slower, tonic, decreases in dopamine were associated with poorer temporal precision. Our findings suggest a delicate and complex role for the dynamics and tone of dopaminergic signals in the conscious experience of time in humans.\nProcess evaluation of a New psychosocial goal-setting and manualised support intervention for Independence in Dementia (NIDUS-Family)\nAuthors: Wyman, D. L.; Butler, L. T.; Morgan-Trimmer, S.; Bright, P.; Barber, J.; Budgett, J.; Walters, K.; Lang, I.; Rapaport, P.; Banks, S.; Palomo, M.; Orgeta, V.; Livingston, G.; Rockwood, K.; Lord, K.; Manthorpe, J.; Dow, B.; Hoe, J.; Cooper, C.\nScore: 6.8, Published: 2024-02-07 DOI: 10.1101/2024.02.06.24302127\nIntroductionWe report a process evaluation embedded within a UK Randomised Controlled Trial (RCT), which demonstrated that New Interventions for independence in Dementia Study (NIDUS)-Family (a manualised, multimodal psychosocial intervention), was effective relative to usual care, on the primary outcome of Goal Attainment Scaling (GAS) over one year. We aimed to test and refine a hypothesised theory of change model delineating key causal assumptions for impact mechanisms. MethodsIn 2021-22, intervention-arm dyads completed an acceptability questionnaire developed to test causal assumptions. We interviewed dyads and their intervention facilitators, purposively selected for diverse follow-up GAS scores and sociodemographic diversity. Matching observational data were collected from intervention session recordings, using a checklist developed to test causal assumptions. We thematically analysed data, then integrated qualitative and quantitative data. Results174/204 (85.3%) dyads allocated to NIDUS-Family, fully completed the intervention, 18 partially completed it, while 12 received none. 47/192 (24.5%) of carers receiving any sessions completed the acceptability questionnaire. 27/58 (47%) dyads purposively selected, and 9/10 facilitators participated in qualitative interviews; and we observed 12 sessions. We identified four themes: A) Someone to talk to helps dyads feel supported; B) NIDUS-Family helps carers change their perspective; C) Personalisation helps people living with dementia maintain their identity; and D) Small steps help dyads move forward. ConclusionKey causal pathway mechanisms were: regular sessions with a consistent facilitator providing space to discuss priorities, supporting carers to consider new perspectives and approaches to personalising care; and planning small actionable steps towards goals. Findings will support NIDUS-Family implementation.\nStructural brain abnormalities and aggressive behaviour in schizophrenia: Mega-analysis of data from 2095 patients and 2861 healthy controls via the ENIGMA consortium\nAuthors: Lamsma, J.; Raine, A.; Kia, S. M.; Cahn, W.; Arold, D.; Banaj, N.; Barone, A.; Brosch, K.; Brouwer, R.; Brunetti, A.; Calhoun, V. D.; Chew, Q. H.; Choi, S.; Chung, Y.-C.; Ciccarelli, M.; Cobia, D.; Cocozza, S.; Dannlowski, U.; Dazzan, P.; de Bartolomeis, A.; Di Forti, M.; Dumais, A.; Edmond, J. T.; Ehrlich, S.; Evermann, U.; Flinkenflugel, K.; Georgiadis, F.; Glahn, D. C.; Goltermann, J.; Green, M. J.; Grotegerd, D.; Guerrero-Pedraza, A.; Ha, M.; Hong, E. L.; Pol, H. H.; Iasevoli, F.; Kaiser, S.; Kaleda, V.; Karuk, A.; Kim, M.; Kircher, T.; Kirschner, M.; Kochunov, P.; Kwon, J. S.; Lebedeva, I\nScore: 3.2, Published: 2024-02-05 DOI: 10.1101/2024.02.04.24302268\nBackgroundSchizophrenia is associated with an increased risk of aggressive behaviour, which may partly be explained by illness-related changes in brain structure. However, previous studies have been limited by group-level analyses, small and selective samples of inpatients and long time lags between exposure and outcome. MethodsThis cross-sectional study pooled data from 20 sites participating in the international ENIGMA-Schizophrenia Working Group. Sites acquired T1-weighted and diffusion-weighted magnetic resonance imaging scans in a total of 2095 patients with schizophrenia and 2861 healthy controls. Measures of grey matter volume and white matter microstructural integrity were extracted from the scans using harmonised protocols. For each measure, normative modelling was used to calculate how much patients deviated (in z-scores) from healthy controls at the individual level. Ordinal regression models were used to estimate the associations of these deviations with concurrent aggressive behaviour (as odds ratios [ORs] with 99% confidence intervals [CIs]). Mediation analyses were performed for positive symptoms (i.e., delusions, hallucinations and disorganised thinking), impulse control and illness insight. Aggression and potential mediators were assessed with the Positive and Negative Syndrome Scale, Scale for the Assessment of Positive Symptoms or Brief Psychiatric Rating Scale. ResultsAggressive behaviour was significantly associated with reductions in total cortical volume (OR [99% CI] = 0.88 [0.78, 0.98], p = .003) and global white matter integrity (OR [99% CI] = 0.72 [0.59, 0.88], p = 3.50 x 10-5) and additional reductions in dorsolateral prefrontal cortex volume (OR [99% CI] = 0.85 [0.74, 0.97], p =.002), inferior parietal lobule volume (OR [99% CI] = 0.76 [0.66, 0.87], p = 2.20 x 10-7) and internal capsule integrity (OR [99% CI] = 0.76 [0.63, 0.92], p = 2.90 x 10-4). Except for inferior parietal lobule volume, these associations were largely mediated by increased severity of positive symptoms and reduced impulse control. ConclusionsThis study provides evidence that the co-occurrence of positive symptoms, poor impulse control and aggressive behaviour in schizophrenia has a neurobiological basis, which may inform the development of therapeutic interventions.\n",
  "wordCount" : "1311",
  "inLanguage": "en",
  "datePublished": "2024-02-14T10:38:48Z",
  "dateModified": "2024-02-14T10:38:48Z",
  "mainEntityOfPage": {
    "@type": "WebPage",
    "@id": "https://trxiv.yorks0n.com/posts/psychiatry-and-clinical-psychology/"
  },
  "publisher": {
    "@type": "Organization",
    "name": "TRxiv2",
    "logo": {
      "@type": "ImageObject",
      "url": "https://trxiv.yorks0n.com/favicon.ico"
    }
  }
}
</script>
</head>

<body class="" id="top">
<script>
    if (localStorage.getItem("pref-theme") === "dark") {
        document.body.classList.add('dark');
    } else if (localStorage.getItem("pref-theme") === "light") {
        document.body.classList.remove('dark')
    } else if (window.matchMedia('(prefers-color-scheme: dark)').matches) {
        document.body.classList.add('dark');
    }

</script>

<header class="header">
    <nav class="nav">
        <div class="logo">
            <a href="https://trxiv.yorks0n.com" accesskey="h" title="TRxiv2 (Alt + H)">TRxiv2</a>
            <div class="logo-switches">
                <button id="theme-toggle" accesskey="t" title="(Alt + T)">
                    <svg id="moon" xmlns="http://www.w3.org/2000/svg" width="24" height="18" viewBox="0 0 24 24"
                        fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round"
                        stroke-linejoin="round">
                        <path d="M21 12.79A9 9 0 1 1 11.21 3 7 7 0 0 0 21 12.79z"></path>
                    </svg>
                    <svg id="sun" xmlns="http://www.w3.org/2000/svg" width="24" height="18" viewBox="0 0 24 24"
                        fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round"
                        stroke-linejoin="round">
                        <circle cx="12" cy="12" r="5"></circle>
                        <line x1="12" y1="1" x2="12" y2="3"></line>
                        <line x1="12" y1="21" x2="12" y2="23"></line>
                        <line x1="4.22" y1="4.22" x2="5.64" y2="5.64"></line>
                        <line x1="18.36" y1="18.36" x2="19.78" y2="19.78"></line>
                        <line x1="1" y1="12" x2="3" y2="12"></line>
                        <line x1="21" y1="12" x2="23" y2="12"></line>
                        <line x1="4.22" y1="19.78" x2="5.64" y2="18.36"></line>
                        <line x1="18.36" y1="5.64" x2="19.78" y2="4.22"></line>
                    </svg>
                </button>
            </div>
        </div>
        <ul id="menu">
        </ul>
    </nav>
</header>
<main class="main">
<article class="post-single">
  <header class="post-header">
    
    <h1 class="post-title">
      psychiatry and clinical psychology
    </h1>
    <div class="post-meta">&lt;span&gt;updated on February 14, 2024&lt;/span&gt;

</div>
  </header> 
  <div class="post-content"><div class="accordion accordion-flush" id="accordionFlushExample"><div class="accordion-item">
    <h3 class="accordion-header" id="flush-heading10.1101/2024.02.02.24302228">
      <button class="accordion-button collapsed" type="button" data-bs-toggle="collapse" data-bs-target="#flush-collapse10.1101/2024.02.02.24302228" aria-expanded="false" aria-controls="flush-collapse10.1101/2024.02.02.24302228">
        <p class="paperTitle">Distinguishing different psychiatric disorders using DDx-PRS</p>
      </button>
    </h3>
    <div id="flush-collapse10.1101/2024.02.02.24302228" class="accordion-collapse collapse" aria-labelledby="flush-heading10.1101/2024.02.02.24302228" data-bs-parent="#accordionFlushExample">
      <div class="accordion-body">
        <p class="author">Authors: Peyrot, W. J.; Panagiotaropoulou, G.; Olde Loohuis, L. M.; Adams, M.; Awasthi, S.; Ge, T.; McIntosh, A. M.; Mitchell, B. L.; Mullins, N.; O&#39;Connell, K. S.; Penninx, B. W. J. H.; Posthuma, D.; Ripke, S.; Ruderfer, D. M.; Uffelmann, E.; Vilhjalmsson, B. J.; Zhu, Z.; Schizophrenia Working Group of the Psychiatric Genomics Consortium,  ; Bipolar Disorder Working Group of the Psychiatric Genomics Consortium,  ; Major Depressive Disorder Working Group of the Psychiatric Genomics Consortium,  ; Smoller, J. W.; Price, A. L.</p>
        <p class="info">Score: 21.5, Published: 2024-02-04 </p>
        <p class="info">DOI: <a href='https://doi.org/10.1101/2024.02.02.24302228' target='https://doi.org/10.1101/2024.02.02.24302228'> 10.1101/2024.02.02.24302228</a></p>
        <p class="abstract">Despite great progress on methods for case-control polygenic prediction (e.g. schizophrenia vs. control), there remains an unmet need for a method that genetically distinguishes clinically related disorders (e.g. schizophrenia (SCZ) vs. bipolar disorder (BIP) vs. depression (MDD) vs. control); such a method could have important clinical value, especially at disorder onset when differential diagnosis can be challenging. Here, we introduce a method, Differential Diagnosis-Polygenic Risk Score (DDx-PRS), that jointly estimates posterior probabilities of each possible diagnostic category (e.g. SCZ=50%, BIP=25%, MDD=15%, control=10%) by modeling variance/covariance structure across disorders, leveraging case-control polygenic risk scores (PRS) for each disorder (computed using existing methods) and prior clinical probabilities for each diagnostic category. DDx-PRS uses only summary-level training data and does not use tuning data, facilitating implementation in clinical settings. In simulations, DDx-PRS was well-calibrated (whereas a simpler approach that analyzes each disorder marginally was poorly calibrated), and effective in distinguishing each diagnostic category vs. the rest. We then applied DDx-PRS to Psychiatric Genomics Consortium SCZ/BIP/MDD/control data, including summary-level training data from 3 case-control GWAS (N=41,917-173,140 cases; total N=1,048,683) and held-out test data from different cohorts with equal numbers of each diagnostic category (total N=11,460). DDx-PRS was well-calibrated and well-powered relative to these training sample sizes, attaining AUCs of 0.66 for SCZ vs. rest, 0.64 for BIP vs. rest, 0.59 for MDD vs. rest, and 0.68 for control vs. rest. DDx-PRS produced comparable results to methods that leverage tuning data, confirming that DDx-PRS is an effective method. True diagnosis probabilities in top deciles of predicted diagnosis probabilities were considerably larger than prior baseline probabilities, particularly in projections to larger training sample sizes, implying considerable potential for clinical utility under certain circumstances. In conclusion, DDx-PRS is an effective method for distinguishing clinically related disorders.</p>
      </div>
    </div>
  </div><div class="accordion-item">
    <h3 class="accordion-header" id="flush-heading10.1101/2024.02.09.24302276">
      <button class="accordion-button collapsed" type="button" data-bs-toggle="collapse" data-bs-target="#flush-collapse10.1101/2024.02.09.24302276" aria-expanded="false" aria-controls="flush-collapse10.1101/2024.02.09.24302276">
        <p class="paperTitle">Sub-second and multi-second dopamine dynamics underlie variability in human time perception</p>
      </button>
    </h3>
    <div id="flush-collapse10.1101/2024.02.09.24302276" class="accordion-collapse collapse" aria-labelledby="flush-heading10.1101/2024.02.09.24302276" data-bs-parent="#accordionFlushExample">
      <div class="accordion-body">
        <p class="author">Authors: Sadibolova, R.; DiMarco, E. K.; Jiang, A.; Maas, B.; Tatter, S. B.; Laxton, A.; Kishida, K. T.; Terhune, D. B.</p>
        <p class="info">Score: 7.5, Published: 2024-02-09 </p>
        <p class="info">DOI: <a href='https://doi.org/10.1101/2024.02.09.24302276' target='https://doi.org/10.1101/2024.02.09.24302276'> 10.1101/2024.02.09.24302276</a></p>
        <p class="abstract">Timing behaviour and the perception of time are fundamental to cognitive and emotional processes in humans. In non-human model organisms, the neuromodulator dopamine has been associated with variations in timing behaviour, but the connection between variations in dopamine levels and the human experience of time has not been directly assessed. Here, we report how dopamine levels in human striatum, measured with sub-second temporal resolution during awake deep brain stimulation surgery, relate to participants perceptual judgements of time intervals. Fast, phasic, dopaminergic signals were associated with underestimation of temporal intervals, whereas slower, tonic, decreases in dopamine were associated with poorer temporal precision. Our findings suggest a delicate and complex role for the dynamics and tone of dopaminergic signals in the conscious experience of time in humans.</p>
      </div>
    </div>
  </div><div class="accordion-item">
    <h3 class="accordion-header" id="flush-heading10.1101/2024.02.06.24302127">
      <button class="accordion-button collapsed" type="button" data-bs-toggle="collapse" data-bs-target="#flush-collapse10.1101/2024.02.06.24302127" aria-expanded="false" aria-controls="flush-collapse10.1101/2024.02.06.24302127">
        <p class="paperTitle">Process evaluation of a New psychosocial goal-setting and manualised support intervention for Independence in Dementia (NIDUS-Family)</p>
      </button>
    </h3>
    <div id="flush-collapse10.1101/2024.02.06.24302127" class="accordion-collapse collapse" aria-labelledby="flush-heading10.1101/2024.02.06.24302127" data-bs-parent="#accordionFlushExample">
      <div class="accordion-body">
        <p class="author">Authors: Wyman, D. L.; Butler, L. T.; Morgan-Trimmer, S.; Bright, P.; Barber, J.; Budgett, J.; Walters, K.; Lang, I.; Rapaport, P.; Banks, S.; Palomo, M.; Orgeta, V.; Livingston, G.; Rockwood, K.; Lord, K.; Manthorpe, J.; Dow, B.; Hoe, J.; Cooper, C.</p>
        <p class="info">Score: 6.8, Published: 2024-02-07 </p>
        <p class="info">DOI: <a href='https://doi.org/10.1101/2024.02.06.24302127' target='https://doi.org/10.1101/2024.02.06.24302127'> 10.1101/2024.02.06.24302127</a></p>
        <p class="abstract">IntroductionWe report a process evaluation embedded within a UK Randomised Controlled Trial (RCT), which demonstrated that New Interventions for independence in Dementia Study (NIDUS)-Family (a manualised, multimodal psychosocial intervention), was effective relative to usual care, on the primary outcome of Goal Attainment Scaling (GAS) over one year. We aimed to test and refine a hypothesised theory of change model delineating key causal assumptions for impact mechanisms.

MethodsIn 2021-22, intervention-arm dyads completed an acceptability questionnaire developed to test causal assumptions. We interviewed dyads and their intervention facilitators, purposively selected for diverse follow-up GAS scores and sociodemographic diversity. Matching observational data were collected from intervention session recordings, using a checklist developed to test causal assumptions. We thematically analysed data, then integrated qualitative and quantitative data.

Results174/204 (85.3%) dyads allocated to NIDUS-Family, fully completed the intervention, 18 partially completed it, while 12 received none. 47/192 (24.5%) of carers receiving any sessions completed the acceptability questionnaire. 27/58 (47%) dyads purposively selected, and 9/10 facilitators participated in qualitative interviews; and we observed 12 sessions. We identified four themes: A)  Someone to talk to helps dyads feel supported; B)  NIDUS-Family helps carers change their perspective; C)  Personalisation helps people living with dementia maintain their identity; and D)  Small steps help dyads move forward.

ConclusionKey causal pathway mechanisms were: regular sessions with a consistent facilitator providing space to discuss priorities, supporting carers to consider new perspectives and approaches to personalising care; and planning small actionable steps towards goals. Findings will support NIDUS-Family implementation.</p>
      </div>
    </div>
  </div><div class="accordion-item">
    <h3 class="accordion-header" id="flush-heading10.1101/2024.02.04.24302268">
      <button class="accordion-button collapsed" type="button" data-bs-toggle="collapse" data-bs-target="#flush-collapse10.1101/2024.02.04.24302268" aria-expanded="false" aria-controls="flush-collapse10.1101/2024.02.04.24302268">
        <p class="paperTitle">Structural brain abnormalities and aggressive behaviour in schizophrenia: Mega-analysis of data from 2095 patients and 2861 healthy controls via the ENIGMA consortium</p>
      </button>
    </h3>
    <div id="flush-collapse10.1101/2024.02.04.24302268" class="accordion-collapse collapse" aria-labelledby="flush-heading10.1101/2024.02.04.24302268" data-bs-parent="#accordionFlushExample">
      <div class="accordion-body">
        <p class="author">Authors: Lamsma, J.; Raine, A.; Kia, S. M.; Cahn, W.; Arold, D.; Banaj, N.; Barone, A.; Brosch, K.; Brouwer, R.; Brunetti, A.; Calhoun, V. D.; Chew, Q. H.; Choi, S.; Chung, Y.-C.; Ciccarelli, M.; Cobia, D.; Cocozza, S.; Dannlowski, U.; Dazzan, P.; de Bartolomeis, A.; Di Forti, M.; Dumais, A.; Edmond, J. T.; Ehrlich, S.; Evermann, U.; Flinkenflugel, K.; Georgiadis, F.; Glahn, D. C.; Goltermann, J.; Green, M. J.; Grotegerd, D.; Guerrero-Pedraza, A.; Ha, M.; Hong, E. L.; Pol, H. H.; Iasevoli, F.; Kaiser, S.; Kaleda, V.; Karuk, A.; Kim, M.; Kircher, T.; Kirschner, M.; Kochunov, P.; Kwon, J. S.; Lebedeva, I</p>
        <p class="info">Score: 3.2, Published: 2024-02-05 </p>
        <p class="info">DOI: <a href='https://doi.org/10.1101/2024.02.04.24302268' target='https://doi.org/10.1101/2024.02.04.24302268'> 10.1101/2024.02.04.24302268</a></p>
        <p class="abstract">BackgroundSchizophrenia is associated with an increased risk of aggressive behaviour, which may partly be explained by illness-related changes in brain structure. However, previous studies have been limited by group-level analyses, small and selective samples of inpatients and long time lags between exposure and outcome.

MethodsThis cross-sectional study pooled data from 20 sites participating in the international ENIGMA-Schizophrenia Working Group. Sites acquired T1-weighted and diffusion-weighted magnetic resonance imaging scans in a total of 2095 patients with schizophrenia and 2861 healthy controls. Measures of grey matter volume and white matter microstructural integrity were extracted from the scans using harmonised protocols. For each measure, normative modelling was used to calculate how much patients deviated (in z-scores) from healthy controls at the individual level. Ordinal regression models were used to estimate the associations of these deviations with concurrent aggressive behaviour (as odds ratios [ORs] with 99% confidence intervals [CIs]). Mediation analyses were performed for positive symptoms (i.e., delusions, hallucinations and disorganised thinking), impulse control and illness insight. Aggression and potential mediators were assessed with the Positive and Negative Syndrome Scale, Scale for the Assessment of Positive Symptoms or Brief Psychiatric Rating Scale.

ResultsAggressive behaviour was significantly associated with reductions in total cortical volume (OR [99% CI] = 0.88 [0.78, 0.98], p = .003) and global white matter integrity (OR [99% CI] = 0.72 [0.59, 0.88], p = 3.50 x 10-5) and additional reductions in dorsolateral prefrontal cortex volume (OR [99% CI] = 0.85 [0.74, 0.97], p =.002), inferior parietal lobule volume (OR [99% CI] = 0.76 [0.66, 0.87], p = 2.20 x 10-7) and internal capsule integrity (OR [99% CI] = 0.76 [0.63, 0.92], p = 2.90 x 10-4). Except for inferior parietal lobule volume, these associations were largely mediated by increased severity of positive symptoms and reduced impulse control.

ConclusionsThis study provides evidence that the co-occurrence of positive symptoms, poor impulse control and aggressive behaviour in schizophrenia has a neurobiological basis, which may inform the development of therapeutic interventions.</p>
      </div>
    </div>
  </div>
</div>









<script src="/js/bundle.min.js" defer></script>



  </div>

  <footer class="post-footer">
    <ul class="post-tags">
    </ul>
  </footer>
</article>
    </main>
    
<footer class="footer">
    <span>&copy; 2024 <a href="https://trxiv.yorks0n.com">TRxiv2</a></span>
    <span>
        Â· Made by Yorkson
    </span>
</footer>
<a href="#top" aria-label="go to top" title="Go to Top (Alt + G)" class="top-link" id="top-link" accesskey="g">
    <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 12 6" fill="currentColor">
        <path d="M12 6H0l6-6z" />
    </svg>
</a>

<script>
    let menu = document.getElementById('menu')
    if (menu) {
        menu.scrollLeft = localStorage.getItem("menu-scroll-position");
        menu.onscroll = function () {
            localStorage.setItem("menu-scroll-position", menu.scrollLeft);
        }
    }

    document.querySelectorAll('a[href^="#"]').forEach(anchor => {
        anchor.addEventListener("click", function (e) {
            e.preventDefault();
            var id = this.getAttribute("href").substr(1);
            if (!window.matchMedia('(prefers-reduced-motion: reduce)').matches) {
                document.querySelector(`[id='${decodeURIComponent(id)}']`).scrollIntoView({
                    behavior: "smooth"
                });
            } else {
                document.querySelector(`[id='${decodeURIComponent(id)}']`).scrollIntoView();
            }
            if (id === "top") {
                history.replaceState(null, null, " ");
            } else {
                history.pushState(null, null, `#${id}`);
            }
        });
    });

</script>
<script>
    var mybutton = document.getElementById("top-link");
    window.onscroll = function () {
        if (document.body.scrollTop > 800 || document.documentElement.scrollTop > 800) {
            mybutton.style.visibility = "visible";
            mybutton.style.opacity = "1";
        } else {
            mybutton.style.visibility = "hidden";
            mybutton.style.opacity = "0";
        }
    };

</script>
<script>
    document.getElementById("theme-toggle").addEventListener("click", () => {
        if (document.body.className.includes("dark")) {
            document.body.classList.remove('dark');
            localStorage.setItem("pref-theme", 'light');
        } else {
            document.body.classList.add('dark');
            localStorage.setItem("pref-theme", 'dark');
        }
    })

</script>
</body>

</html>
